2016 Canadian Conference on Ovarian Cancer Research: Intensify Innovation, Improve Impact

Eric Asselin

Gene therapy of chemoresistant and metastatic cancers (CANADA RESEARCH CHAIRHOLDER)

Ovary Corpus uteri

The Role of microRNA, mir-30d, in the Initiation and Progression of Cancer

Ovary Breast

Meir Stampfer

Dietary and Hormonal Determinants of Cancer in Women

Ovary Colorectum Breast

Dipanjan Chowdhury

Molecular mechanism and relevance of microRNAs in DSB repair pathway choice

Ovary Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology Radiation Oncology

Michelle Hildebrandt

Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors

Ovary

Norman Wolmark

NRG Oncology Network Group Operations Center

Trachea, bronchus and lung Stomach Prostate Pancreas Ovary Oesophagus Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast Brain, nervous system Bladder

Radiation Oncology Surgery / Surgical oncology

Jeffrey Gildersleeve

Serum Antibody Profiling with a Carbohydrate Microarray

Trachea, bronchus and lung Prostate Ovary

Pathology

Shahinaz Gadalla

Cancer Risk in Myotonic Dystrophy

Ovary Non-Melanoma skin cancer Corpus uteri Colorectum Brain, nervous system

Nicolas Wentzensen

AMH, Inhibin A, FSH, and Ovarian Cancer Risk in the JANUS Serum Bank

Ovary

Hematology and hematologic malignancies Pathology